UY32636A - Piperidinas sustituidas - Google Patents

Piperidinas sustituidas

Info

Publication number
UY32636A
UY32636A UY0001032636A UY32636A UY32636A UY 32636 A UY32636 A UY 32636A UY 0001032636 A UY0001032636 A UY 0001032636A UY 32636 A UY32636 A UY 32636A UY 32636 A UY32636 A UY 32636A
Authority
UY
Uruguay
Prior art keywords
piperidins
substituted
prophylaxis
diseases
treatment
Prior art date
Application number
UY0001032636A
Other languages
English (en)
Inventor
Dr Dirk Heimbach
Dr Eckhard Bender
Dr Katja Zimmermann
Gerdes Dr Christoph
Dr Mark Jean Gnoth
Dr Susanne Roehrig
Dr Yolanda Cancho-Grande
Buchmueller Dr Anja
Kersten Matthias Gericke
Jeske Dr Mario
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of UY32636A publication Critical patent/UY32636A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

La invención se refiere a nuevas piperidinas sustituidas, a procedimientos para su preparación, al uso de las mismas para tratamiento y/o profilaxis de enfermedades y al uso de las mismas para la producción de medicamentos para tratamiento y/o profilaxis de enfermedades, especialmente de trastornos cardiovasculares y trastornos tumorales.
UY0001032636A 2009-05-27 2010-05-13 Piperidinas sustituidas UY32636A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102009022896A DE102009022896A1 (de) 2009-05-27 2009-05-27 Substituierte Piperidine

Publications (1)

Publication Number Publication Date
UY32636A true UY32636A (es) 2010-12-31

Family

ID=42543057

Family Applications (2)

Application Number Title Priority Date Filing Date
UY0001032636A UY32636A (es) 2009-05-27 2010-05-13 Piperidinas sustituidas
UY0001032638A UY32638A (es) 2009-05-18 2010-05-13 Manoproteínas para uso en zumo de frutas

Family Applications After (1)

Application Number Title Priority Date Filing Date
UY0001032638A UY32638A (es) 2009-05-18 2010-05-13 Manoproteínas para uso en zumo de frutas

Country Status (28)

Country Link
US (2) US20120220563A1 (es)
EP (1) EP2435427A1 (es)
JP (1) JP5718320B2 (es)
KR (1) KR20120044289A (es)
CN (2) CN102596944B (es)
AR (1) AR076692A1 (es)
AU (1) AU2010252345A1 (es)
BR (1) BRPI1012055A2 (es)
CA (1) CA2763400A1 (es)
CL (1) CL2011002965A1 (es)
CO (1) CO6470823A2 (es)
CR (1) CR20110628A (es)
CU (1) CU20110215A7 (es)
DE (1) DE102009022896A1 (es)
DO (1) DOP2011000364A (es)
EA (1) EA201190312A1 (es)
EC (2) ECSP11011483A (es)
GT (1) GT201100300A (es)
IL (1) IL215901A0 (es)
MA (1) MA33290B1 (es)
MX (1) MX2011012505A (es)
PE (1) PE20120934A1 (es)
SG (1) SG175753A1 (es)
TN (1) TN2011000595A1 (es)
TW (1) TW201109326A (es)
UY (2) UY32636A (es)
WO (1) WO2010136144A1 (es)
ZA (1) ZA201108565B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009014484A1 (de) 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022896A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022894A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022892A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
BR112014007257B1 (pt) 2011-10-07 2023-04-25 Takeda Pharmaceutical Company Limited Composto 1-arilcarbonil-4-oxi-piperidina
AU2017252546B2 (en) 2016-04-20 2021-07-29 Bristol-Myers Squibb Company Substituted bicyclic heterocyclic compounds
SG11201903871TA (en) 2016-11-03 2019-05-30 Bristol Myers Squibb Co Substituted bicycle heterocyclic derivatives useful as romk channel inhibitors
PL3630752T3 (pl) 2017-06-01 2021-11-02 Bristol-Myers Squibb Company Podstawione związki zawierające azot
WO2023044364A1 (en) 2021-09-15 2023-03-23 Enko Chem, Inc. Protoporphyrinogen oxidase inhibitors

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767144A (en) * 1994-08-19 1998-06-16 Abbott Laboratories Endothelin antagonists
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US6403612B2 (en) * 2000-01-31 2002-06-11 Merck & Co., Inc. Thrombin receptor antagonists
ATE345799T1 (de) 2001-10-15 2006-12-15 Janssen Pharmaceutica Nv Substituierte 4-phenyl-4-(1h-imidazol-2-yl)- piperidinderivate zur verringerung von ischämischer schädigung
WO2003074495A1 (en) * 2002-03-01 2003-09-12 Smithkline Beecham Corporation Hppars activators
WO2006002349A1 (en) 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
MXPA06014574A (es) * 2004-06-24 2007-03-12 Incyte Corp Piperidinas n-sustituidas y su uso como farmaceuticos.
CN1993128A (zh) * 2004-06-24 2007-07-04 因塞特公司 N-取代的哌啶及它们作为药物的用途
JP2008504279A (ja) 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用
EA200700251A1 (ru) 2004-08-10 2007-08-31 Инсайт Корпорейшн Амидосоединения и их применение в качестве фармацевтических средств
JP2007008913A (ja) * 2004-09-17 2007-01-18 Tanabe Seiyaku Co Ltd ピペリジン化合物およびその製法
DE102004045796A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
DE102004061750A1 (de) * 2004-12-22 2006-07-06 Bayer Healthcare Ag Heteroaryl-substituierte Pyrazoline
CA2621255A1 (en) 2005-09-21 2007-04-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
WO2007089683A1 (en) 2006-01-31 2007-08-09 Incyte Corporation Amido compounds and their use as pharmaceuticals
TW200808807A (en) 2006-03-02 2008-02-16 Incyte Corp Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
WO2007130898A1 (en) 2006-05-01 2007-11-15 Incyte Corporation TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
DK2227466T3 (da) 2007-11-30 2011-08-08 Bayer Schering Pharma Ag Heteroaryl-substituerede piperidiner
DE102009014484A1 (de) * 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022896A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022897A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022894A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine

Also Published As

Publication number Publication date
JP5718320B2 (ja) 2015-05-13
KR20120044289A (ko) 2012-05-07
US8084469B2 (en) 2011-12-27
JP2012528090A (ja) 2012-11-12
EA201190312A1 (ru) 2012-05-30
DOP2011000364A (es) 2012-02-29
GT201100300A (es) 2013-08-21
DE102009022896A1 (de) 2010-12-02
TW201109326A (en) 2011-03-16
UY32638A (es) 2010-10-29
AR076692A1 (es) 2011-06-29
US20120220563A1 (en) 2012-08-30
CN102596944A (zh) 2012-07-18
BRPI1012055A2 (pt) 2016-05-17
ZA201108565B (en) 2013-01-30
ECSP11011483A (es) 2011-12-30
CN104744452A (zh) 2015-07-01
TN2011000595A1 (en) 2013-05-24
AU2010252345A1 (en) 2011-12-08
CO6470823A2 (es) 2012-06-29
CR20110628A (es) 2012-03-22
PE20120934A1 (es) 2012-08-01
CA2763400A1 (en) 2010-12-02
SG175753A1 (en) 2011-12-29
EP2435427A1 (de) 2012-04-04
IL215901A0 (en) 2012-01-31
CN102596944B (zh) 2015-08-26
MX2011012505A (es) 2011-12-14
CU20110215A7 (es) 2012-03-15
CL2011002965A1 (es) 2012-07-06
WO2010136144A1 (de) 2010-12-02
ECSP11011482A (es) 2011-12-30
MA33290B1 (fr) 2012-05-02
US20110021489A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
ECSP11011482A (es) Piperidinas sustituidas
CY1117372T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες και η χρηση τους
CL2018000039A1 (es) Derivados de oxopiridina sustituidos
PA8784001A1 (es) Oxazolidinonas sustituidas y su uso
DOP2009000205A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso
WO2013151665A3 (en) Modified polynucleotides for the production of proteins associated with human disease
DK3045456T3 (da) Bicyklisk substituerede uraciler og anvendelse heraf
SV2011004019A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
EA201491028A1 (ru) Способ получения замещенных 5-фтор-1н-пиразолопиридинов
DK2243772T3 (da) Hidtil ukendte P2X7R-antagonister og deres anvendelse
CR20140553A (es) Compuestos de fenoxietil piperidina
CO6470822A2 (es) Piperidinas susituidas
EA201400623A1 (ru) Новые 2h-индазолы в качестве антагонистов рецептора ep
UY35746A (es) Derivados de fenilalanina sustituidos
UY31508A1 (es) Triazolotriazinas y triazolopirazinas y su uso
DE502007006625D1 (de) 3-cyano-5-thiazaheteroaryl-dihydropyridine und ihrnkungen
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.
UY35592A (es) Benzoxazoles sustituidos
BR112013006307A2 (pt) fenilacetamidas e fenilpropanamidas substituídas e o seu uso
UA111139C2 (uk) Тверді фармацевтичні композиції і способи їхнього отримання

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181129